Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Oramed Pharmaceuticals Inc
ORMP | US
3.60
USD-0.29
-7.46%
ORMP | US
Loading StockChartView...
About Oramed Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
3.60
Open
3.85
High
3.96
Low
3.58
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's product portfolio includes ORMD-0801 Type 2 an orally ingestible insulin capsule which completed phase II clinical trials for the treatment of individuals with diabetes; ORMD-0801 Phase 2 oral insulin capsule for non-alcoholic steatohepatitis a progressive liver diseases; and ORMD-0901 an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.
View LessORMP | US
Risk
74.2
Sharpe
1.15
Luna's Score
33/100
Recommendation
Sell
Luna says (ORMP | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
58.6%1 month
74.2%3 months
56.2%6 months
56.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
4.54
Fwd. PE
-
Price to book
0.53
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
0.52
Ent. to rev.
2.86
PEG
-
Other Fundamentals
EBITDA
-12.65M
MarketCap
146.77M
MarketCap(USD)
146.77M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-100.00
Ret. on equity
12.70
Short ratio
3.47
Short perc.
0.92
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.85
Range1M
1.43
Range3M
1.86
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.82
Price X volume
1.40M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.52 | 0.53 | Par |
| Ent. to Revenue | 2.86 | 3,967.00 | Cheaper |
| PE Ratio | 4.54 | 41.03 | Cheaper |
| Price to Book | 0.53 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 56.19 | 72.80 | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 146.77M | 3.66B | Emerging |
